Trial intelligence / Profile preview

Betamethasone for perioperative renal protection in elderly abdominal surgery patients

ChiCTR2000034472Phase 4Recruiting

Sponsor
The Second Xiangya Hospital
Start
Jul 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of betamethasone in acute kidney failure (AKF) (3 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Urinary NAG/Cr and Urinary Alb/Cr. Started Jul 2020; status: recruiting.

02

Drugs

betamethasone
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on ChiCTR2000034472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call